Not Medicare Enrolled

Dr. Charles Pryzant, M.D.

Child & Adolescent Psychiatry Physician · Dallas, TX
5925 FOREST LANE, Dallas, TX 75230
9726618739
Registered in NPPES since 2007
NPI: 1780881508 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pryzant from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pryzant? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pryzant

Dr. Charles Pryzant is a child & adolescent psychiatry physician in Dallas, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Pryzant received a total of $6,698 from 27 pharmaceutical and/or device companies across 286 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pryzant is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $6,698 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,698
Total received (2018-2024)
Avg $957/year across 7 years
Top 8% in TX for child & adolescent psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
286
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,657
2023
$1,092
2022
$2,466
2021
$786
2020
$404
2019
$231
2018
$62

Payments by company (2024)

Supernus Pharmaceuticals, Inc.
$486
ABBVIE INC.
$235
Corium, LLC
$207
Otsuka America Pharmaceutical, Inc.
$166
IRONSHORE PHARMACEUTICALS INC.
$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$114
Alkermes, Inc.
$84
Janssen Pharmaceuticals, Inc
$53
Lundbeck LLC
$40
IDORSIA PHARMACEUTICALS US INC
$35
Takeda Pharmaceuticals U.S.A., Inc.
$35
Axsome Therapeutics, Inc.
$27
Neurocrine Biosciences, Inc.
$21
Vertical Pharmaceuticals, LLC
$17
Top 3 companies account for 56.0% of 2024 payments
All-time payments by company (2018-2024) ›
Corium, LLC
$1,890
Supernus Pharmaceuticals, Inc.
$635
ABBVIE INC.
$535
Otsuka America Pharmaceutical, Inc.
$506
Tris Pharma Inc
$362
Janssen Pharmaceuticals, Inc
$337
Takeda Pharmaceuticals U.S.A., Inc.
$334
Alkermes, Inc.
$283
ITI, Inc.
$244
Ironshore Pharmaceuticals Inc.
$243
Sunovion Pharmaceuticals Inc.
$160
AbbVie Inc.
$150
IRONSHORE PHARMACEUTICALS INC.
$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$114
Neos Therapeutics, LP
$108
Neurocrine Biosciences, Inc.
$94
Shire North American Group Inc
$87
Adlon Therapeutics L.P.
$83
Lundbeck LLC
$64
Allergan Inc.
$63
Noven Therapeutics, LLC
$55
IDORSIA PHARMACEUTICALS US INC
$48
Eisai Inc.
$47
Vertical Pharmaceuticals, LLC
$43
Neuronetics, Inc.
$28
Axsome Therapeutics, Inc.
$27
Corium, Inc.
$20
Top 3 companies account for 45.7% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ADHANSIA XR · ARISTADA · AZSTARYS · Adzenys XR-ODT · Auvelity · Azstarys · BRINTELLIX · CAPLYTA · COTEMPLA XR-ODT · Cotempla XR-ODT · DIVIGEL · Dayvigo · Dyanavel XR · Entyvio · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · MYDAYIS · NEUROSTAR TMS THERAPY · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · Quillivant XR · REXULTI · Relexxii · SPRAVATO · Secuado · TRINTELLIX · VRAYLAR · VYVANSE
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a child & adolescent psychiatry physician in Dallas?
Compare child & adolescent psychiatry physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & adolescent psychiatry physicians in nearby ZIP areas
64
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pryzant is a child & adolescent psychiatry physician, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Pryzant receive payments from pharmaceutical companies?
Yes. Dr. Pryzant received a total of $6,698 from 27 companies across 286 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Pryzant) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Child & Adolescent Psychiatry Physicians in Dallas
Browse child & adolescent psychiatry physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Child & Adolescent Psychiatry Physicians in TX
Child & adolescent psychiatry physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Child & Adolescent Psychiatry Physicians in TX
Which TX child & adolescent psychiatry physicians receive the most from drug and device companies.
By company
Corium, LLC Payments to Doctors
See all physicians who received payments from Corium, LLC.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →